Posterior scapular lymph nodes in a patient with follicular lymphoma on whole-body 2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT)

被引：0
|
作者：
Mahmood, S. [1 ,2 ]
de Liano, S. R. Martinez [3 ,4 ]
机构：
[1] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Nucl Med, Bronx, NY 10461 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, Nucl Med Serv, New York, NY 10021 USA
[3] Univ London Imperial Coll Sci Technol & Med, Fac Med, Hammersmith Hosp, MRC,Clin Sci Ctr, London, England
[4] Univ London Imperial Coll Sci Technol & Med, Fac Med, Hammersmith Hosp, Div Neurosci, London, England
来源：
REVISTA ESPANOLA DE MEDICINA NUCLEAR | 2008年 / 27卷 / 03期
关键词：
D O I：
10.1157/13121031
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：202 / 203
页数：2
相关论文
共 50 条
  • [31] A prospective evaluation of the utility of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer
    Smyth, Elizabeth
    Schoeder, Heiko
    Strong, Vivian E.
    Capanu, Marinela
    Kelsen, David P.
    Coit, Daniel G.
    Shah, Manish A.
    CANCER, 2012, 118 (22) : 5481 - 5488
  • [32] Positron emission tomography agent 2-deoxy-2-[18F] fluoro-D-glucose has a therapeutic potential in breast cancer
    Moadel, RM
    Nguyen, AV
    Lin, EY
    Lu, P
    Mani, J
    Blaufox, MD
    Pollard, JW
    Dadachova, E
    BREAST CANCER RESEARCH, 2003, 5 (06) : R199 - R205
  • [33] The role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor
    Obrzut, SL
    Halpern, BS
    Monchamp, T
    Grabski, K
    Watts, WJ
    Czernin, J
    MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (03) : 126 - 130
  • [34] 2-Deoxy-2-[18F] Fluoro-D-Glucose PET/Computed Tomography Therapy Response Assessment in Head and Neck Cancer
    Sheikhbahaei, Sara
    Subramaniam, Rathan M.
    Solnes, Lilja B.
    PET CLINICS, 2022, 17 (02) : 307 - 317
  • [35] Evaluation of metastatic meningioma with 2-deoxy-2-[18F]fluoro-D-glucose PET/CT
    Ghodsian, M
    Obrzut, SL
    Hyde, CC
    Watts, WJ
    Schiepers, C
    CLINICAL NUCLEAR MEDICINE, 2005, 30 (11) : 717 - 720
  • [36] Tracheal involvement in ulcerative colitis: clinical presentation and potential interest of 2-deoxy-2[18F]fluoro-D-glucose positron emission tomography (18F-FDG PET) for the management
    Jouan, Youenn
    Venel, Yann
    Lioger, Bertrand
    du Sorbier, Christophe Monegier
    Gaucher, Luc
    Marchand-Adam, Sylvain
    Diot, Patrice
    Diot, Elisabeth
    ANNALS OF NUCLEAR MEDICINE, 2012, 26 (10) : 830 - 834
  • [37] The value of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG PET) in diagnosis of neoplastic diseases
    Hernández, GR
    Avalos, CRDY
    Delgado, JLC
    MEDICINA CLINICA, 2005, 124 (06): : 229 - 236
  • [38] Tracheal involvement in ulcerative colitis: clinical presentation and potential interest of 2-deoxy-2[18F]fluoro-d-glucose positron emission tomography (18F-FDG PET) for the management
    Youenn Jouan
    Yann Venel
    Bertrand Lioger
    Christophe Monegier du Sorbier
    Luc Gaucher
    Sylvain Marchand-Adam
    Patrice Diot
    Elisabeth Diot
    Annals of Nuclear Medicine, 2012, 26 : 830 - 834
  • [39] Performance of 2-Deoxy-2-[F-18]fluoro-d-glucose Positron Emission Tomography and Integrated PET/CT in Restaged Breast Cancer Patients
    Barbara J. Fueger
    Wolfgang A. Weber
    Andrew Quon
    Tyler L. Crawford
    M. S. Allen-Auerbach
    B. S. Halpern
    Osman Ratib
    Michael E. Phelps
    Johannes Czernin
    Molecular Imaging and Biology, 2005, 7 : 369 - 376
  • [40] Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients
    Fueger, BJ
    Weber, WA
    Quon, A
    Crawford, TL
    Allen-Auerbach, MS
    Halpern, BS
    Ratib, O
    Phelps, ME
    Czernin, J
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (05) : 369 - 376
12345